<jats:p>Actinomycetes, especially species of <jats:italic>Streptomyces</jats:italic> are prolific producers of pharmacologically significant compounds accounting for about 70% of the naturally derived antibiotics that are presently in clinical use. In this study, we used five solvents to extract the secondary metabolites from marine <jats:italic>Streptomyces parvulus</jats:italic> DOSMB-D105, which was isolated from the mangrove sediments of the South Andaman Islands. Among them, ethyl acetate crude extract showed maximum activity against 11 pathogenic bacteria and six fungi. Presence of bioactive compounds in the ethyl acetate extract was determined using GC-MS and the compounds detected in the ethyl acetate extract were matched with the National Institute of Standards and Technology (NIST) library. Totally eight compounds were identified and the prevalent compounds were 2 steroids, 2 alkaloids, 2 plasticizers, 1 phenolic and 1 alkane. Present study revealed that <jats:italic>S. parvulus</jats:italic> DOSMB-D105 is a promising species for the isolation of valuable bioactive compounds to combat pathogenic microbes.